6abc News: Fox Chase-Temple Urologic Institute is advancing treatment for benign prostatic hyperplasia
PHILADELPHIA (WPVI) -- Benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate gland, is the most common benign tumor found in men. BPH produces symptoms by obstructing the flow ...
Medical Xpress: Holmium Laser of the Prostate Double-n Technology promising for benign prostatic hyperplasia
For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ...
Holmium Laser of the Prostate Double-n Technology promising for benign prostatic hyperplasia
Credit: Getty Images This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men. Familial clustering studies ...
Benign Prostatic Hyperplasia: Causes, Symptoms, Diagnosis, and Treatments: By Anjali Srivastava Benign Prostatic Hyperplasia (BPH) is a common condition that affects many men as they age, involving ...
Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...
Kaleido Scope: UAB to now offer aquablation therapy for benign prostatic hyperplasia
The most common prostate condition in men over the age of 50 is benign prostatic hyperplasia, a noncancerous condition that impacts the prostate gland. BPH is when the prostate enlarges and constricts ...
Renal & Urology News: Benign Prostatic Hyperplasia vs Prostate Cancer: An Overview
Extracts of the berries of saw palmetto, a small palm tree native to the southeastern U.S., are used widely to treat benign prostatic hyperplasia (BPH). In this randomized trial conducted in ...
The American Journal of Managed Care: α-Blocker Treatment Linked to Worse Cardiovascular Outcomes in Patients With Benign Prostatic Hyperplasia
These new findings are important as α-blockers (ABs) are the most prescribed class of medications for patients with benign prostatic hyperplasia (BPH), but the cardiovascular safety profile of this ...
α-Blocker Treatment Linked to Worse Cardiovascular Outcomes in Patients With Benign Prostatic Hyperplasia
A head-to-head trial of minimally invasive procedures to manage benign prostatic hyperplasia found that urethral implants appear to provide more durable control of symptoms than thermal therapy. The ...